Stuart H Isaacson Selected Research

Stuart H Isaacson Research Topics

Disease

27	Parkinson Disease (Parkinson's Disease) 06/2022 - 07/2009
7	Dyskinesias (Dyskinesia) 06/2022 - 07/2009
4	Edema (Dropsy) 01/2021 - 01/2010
4	Hallucinations (Hallucination) 01/2021 - 01/2010
3	Orthostatic Hypotension (Postural Hypotension) 03/2022 - 01/2014
3	Disease Progression 01/2020 - 07/2009
2	Torticollis (Wryneck) 01/2022 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 01/2020
2	Parkinsonian Disorders (Parkinsonism) 01/2021 - 01/2017
2	Tremor (Tremors) 01/2021 - 01/2020
2	Constipation 01/2020 - 10/2018
1	Cognitive Dysfunction 07/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Injection Site Reaction 11/2021
1	Nausea 01/2021
1	Hyperkinesis 01/2021
1	Tardive Dyskinesia 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Infections 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Sialorrhea 01/2020
1	Gastroparesis 01/2020
1	Essential Tremor (Essential Tremors) 01/2020
1	Atrial Fibrillation 01/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Headache (Headaches) 10/2018
1	Diarrhea 10/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018
1	Movement Disorders (Movement Disorder) 03/2018
1	Wounds and Injuries (Trauma) 09/2016
1	Dizziness (Lightheadedness) 09/2016
1	Gout 02/2014
1	Urolithiasis 02/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2010

Drug/Important Bio-Agent (IBA)

11	Levodopa (L Dopa)FDA LinkGeneric 11/2021 - 07/2009
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2018
4	Amantadine (Aman)FDA LinkGeneric 01/2020 - 01/2017
3	DroxidopaIBA 03/2022 - 01/2014
2	Antipsychotic Agents (Antipsychotics)IBA 07/2022 - 01/2021
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 06/2022 - 01/2019
2	Carbidopa (Lodosyn)FDA LinkGeneric 11/2021 - 07/2009
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021 - 01/2017
2	pimavanserinIBA 01/2021 - 01/2020
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2016 - 01/2014
2	Selegiline (E250)FDA LinkGeneric 02/2011 - 01/2010
1	TabletsIBA 06/2022
1	SuspensionsIBA 06/2022
1	GlycosphingolipidsIBA 01/2022
1	venglustatIBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	incobotulinumtoxinA FDA Link 01/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022
1	Glucosylceramides (Glucocerebrosides)IBA 01/2022
1	Apomorphine FDA Link 12/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2021
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2021
1	Carboxy-LyasesIBA 01/2021
1	istradefyllineIBA 01/2021
1	abobotulinumtoxinA FDA Link 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2020
1	rimabotulinumtoxinB FDA Link 01/2020
1	Dopa DecarboxylaseIBA 01/2019
1	rotigotine FDA Link 01/2019
1	PowdersIBA 01/2019
1	SynucleinsIBA 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	ioflupaneIBA 01/2017
1	ProdrugsIBA 09/2016
1	Biological ProductsIBA 02/2014
1	Uric Acid (Urate)IBA 02/2014
1	Inosine FDA Link 02/2014
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2010
1	amsonic acid (DAS)IBA 01/2010
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2010
1	ropinirole (Requip)FDA LinkGeneric 01/2010
1	Dopamine (Intropin)FDA LinkGeneric 11/2009
1	StalevoIBA 07/2009
1	entacapone (Comtan)FDA Link 07/2009

Therapy/Procedure

6	Therapeutics 06/2022 - 01/2020
1	Injections 01/2020
1	Activities of Daily Living (ADL) 01/2020
1	Wearable Electronic Devices 01/2019